sVEGFR3
Biomarker1 paper1 finding
- Humans1
Interventions
1SGLT2 inhibitors
upin humans1Very low certainty
1 study
SGLT2 inhibitors
upin humans1Very low certainty
SGLT2 inhibitors increase sVEGFR3 in humans (82.3 ± 4.7 vs. 63.3 ± 3.9 pg/mL).
Humansin advanced heart failure
SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure · Journal of molecular and cellular cardiology plus · 16 Aug 2026
Latest
1Journal of Molecular and Cellular Cardiology PlusHumans